Pepto Relief
NDC 54738-102, Bismuth subsalicylate, tablet, chewable, from Richmond Pharmaceuticals, Inc.
- Product NDC
- 54738-102
- Status
- Listed
- Labeler
- Richmond Pharmaceuticals, Inc
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH FINAL
- Application
- part335
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54738-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BISMUTH SUBSALICYLATE262 mg/1
Pharmacologic classes
Bismuth [CS]; Bismuth [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54738-102-30 | 54738010230 | 30 TABLET, CHEWABLE in 1 BOTTLE (54738-102-30) |
| 54738-102-48 | 54738010248 | 48 TABLET, CHEWABLE in 1 BOTTLE (54738-102-48) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 54738-102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54738-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54738-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.